18191411000001104: Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Clindamycin\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Clindamycin\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\UK product\Trade family\Dalacin C\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Clindamycin\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Clindamycin\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing clindamycin\Product containing clindamycin in oral dose form (medicinal product form)\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Clindamycin\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Clindamycin\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing clindamycin\Product containing clindamycin in oral dose form (medicinal product form)\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Clindamycin\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Clindamycin\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing clindamycin\Product containing clindamycin in oral dose form (medicinal product form)\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing clindamycin in oral dose form (medicinal product form)\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

62431601000001110 Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

62431701000001117 Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Clindamycin hydrochloride	false	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Clindamycin hydrochloride	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Clindamycin	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Dalacin C	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Has basis of strength substance	Clindamycin	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd) 24 capsule	Has AMP	True	Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
62431601000001110	Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
62431701000001117	Dalacin C 150mg capsules (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module